Symposium 10

Symposium 10：Treatment Strategies for Acute Respiratory Distress Syndrome due to Coronavirus Disease 2019

Acute respiratory distress syndrome (ARDS) is a severe pulmonary disease with high mortality. Besides the traditional protective lung ventilation strategy, recent treatment modalities have shown promising results. High-flow nasal cannula is employed in early ARDS due to Coronavirus disease 2019 (COVID-19). Besides the survival benefits in moderate to severe ARDS, prone positioning has been widely applied for COVID-19 patients, either intubated or non-intubated. Extracorporeal membrane oxygenation (ECMO) has also been used largely in patients with COVID-19 with acute respiratory distress syndrome during the pandemic. This symposium will discuss and summarize the evidence and recommendations about the three aforementioned treatment modalities for ARDS, especially due to COVID-19. The speakers will also share their clinical experiences in treating ARDS patietns.